MCDCX
Price
$18.95
Change
+$0.27 (+1.45%)
Updated
Jan 30 closing price
Net Assets
4.04B
VEMAX
Price
$37.12
Change
+$0.41 (+1.12%)
Updated
Jan 30 closing price
Net Assets
108.96B
Ad is loading...

MCDCX vs VEMAX

Header iconMCDCX vs VEMAX Comparison
Open Charts MCDCX vs VEMAXBanner chart's image
BlackRock Emerging Mkts Inv C
Price$18.95
Change+$0.27 (+1.45%)
VolumeN/A
Net Assets4.04B
Vanguard Emerging Mkts Stock Idx Adm
Price$37.12
Change+$0.41 (+1.12%)
VolumeN/A
Net Assets108.96B
MCDCX vs VEMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MCDCX vs. VEMAX commentary
Jan 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MCDCX is a Buy and VEMAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEMAX has more cash in the bank: 109B vs. MCDCX (4.04B). VEMAX pays higher dividends than MCDCX: VEMAX (3.43) vs MCDCX (1.05). MCDCX was incepted earlier than VEMAX: MCDCX (30 years) vs VEMAX (19 years). MCDCX is a more actively managed with annual turnover of: 96.00 vs. VEMAX (5.00). MCDCX has a lower initial minimum investment than VEMAX: MCDCX (1000) vs VEMAX (3000). VEMAX annual gain was more profitable for investors over the last year : 13.85 vs. MCDCX (4.14). VEMAX return over 5 years is better than : 15.47 vs. MCDCX (-3.28).
MCDCXVEMAXMCDCX / VEMAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence30 years19 years-
Gain YTD1.391-0.163-853%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRA100N/A-
Net Assets4.04B109B4%
Annual Yield % from dividends1.053.4331%
Returns for 1 year4.1413.8530%
Returns for 3 years-17.88-4.03444%
Returns for 5 years-3.2815.47-21%
Returns for 10 years24.4029.0384%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNVS3.660.16
+4.57%
Cineverse Corp
SABR3.390.08
+2.42%
Sabre Corp
PTCT46.150.93
+2.06%
PTC Therapeutics
OPRX5.710.05
+0.88%
OptimizeRx Corp
K81.940.17
+0.21%
Kellanova